PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People\'s Republic of China.\', \'Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People\'s Republic of China.\', \'Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/22221751.2020.1780953
?:doi
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 32529952
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all